Nurses Supporting Harm Reduction: How Take-Home Naloxone is Conceived in the Context of Neoliberalism
DOI:
https://doi.org/10.25071/2291-5796.138Keywords:
Neoliberalism, take-home-naloxone, harm reduction, discourse, nursingAbstract
Introduction – Individuals must be personally invested in their own recovery journey; however, the neoliberal perspective absolves the state of responsibility of this work and makes promotion of health merely an individual action. Naloxone distribution, as a harm reduction strategy, is presented herein as one practice engaged by nurses that demonstrates philosophical tension between neoliberalism and harm reduction.
Background Literature – The research literature supporting the provision of take-home naloxone (THN), non-medically administered, is significant and broad.
Discussion – The problem with neoliberal discourses of constrained healthcare resources in this case is that without broad availability of naloxone, drug poisonings will continue unchecked. There is an ethical call to nurses to support broad distribution of naloxone regardless of the costs involved.
Conclusion – THN is not only a best practice to reduce the harms of substance use, but it is also a political and philosophical act to hand over the control of public health resources to the public.
Downloads
References
Baker, T., McCann, E., & Temenos, C. (2020). Into the ordinary: non-elite actors and the mobility of harm reduction policies. Policy and Society, 39(1), 129-145, https://doi.org/10.1080/14494035.2019.1626079
Ball, A. (2007). HIV, injecting drug use and harm reduction: a public health response. Addiction, 102(5), 684-690. https://doi.org/10.111/j.1360-0443.2007.01761.x
Boyd, S., Carter, C., & MacPherson, D. (2016). More harm than good: Drug policy in Canada. Fernwood Publishing.
Canadian Community Epidemiology Network on Drug Use. (2016). The availability of Take-Home Naloxone in Canada. https://www.ccsa.ca/sites/default/files/2019-05/CCSA-CCENDU-Take-Home-Naloxone-Canada-2016-en.pdf
Canadian Nurses Association. (2018). Harm reduction and substance use: Joint statement. https://www.cna-aiic.ca/-/media/cna/page-content/pdf-en/joint_position_statement_harm_reduction_and_substance_use.pdf
Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of addiction medicine, 8(3), 153–163. https://doi.org/10.1097/ADM.0000000000000034
Coffin, P. O., & Sullivan, S. D. (2013). Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. Journal of medical economics, 16(8), 1051–1060. https://doi.org/10.3111/13696998.2013.811080
Crawford, M. (2021). Health Care and the Limits of “Progressive” Neoliberalism: Re-Evaluating the Trade-Health Interface 2006-2019. Interventions Économiques Pour Une Alternative Sociale, 65(65). https://doi.org/10.4000/interventionseconomiques.12308
Elliott, D. (2014). Debating Safe injecting sites in Vancouver’s inner city: Advocacy, conservativism and neoliberalism. Contemporary Drug Problems, 41(1), 5-40. http://cdx.sagepub.com.libproxy.wlu.ca/content/41/1/5
Faulkner-Gurstein, R. (2017). The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social science & medicine (1982), 180, 20–27. https://doi.org/10.1016/j.socscimed.2017.03.013
Gill, J. K. (2021). Unpacking the Role of Neoliberalism on the Politics of Poverty Reduction Policies in Ontario, Canada: A Descriptive Case Study and Critical Analysis. Social Sciences (Basel), 10(12), 485–. https://doi.org/10.3390/socsci10120485
Gordon, T. (2006). Neoliberalism, Racism, and the War on Drugs in Canada. Social Justice, 33(1 (103)), 59–78. http://www.jstor.org/stable/29768352
Government of Canada. (2022). Naloxone. https://www.canada.ca/en/health-canada/services/opioids/naloxone.html
Green, T. C., Dauria, E. F., Bratberg, J., Davis, C. S., & Walley, A. Y. (2015). Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm reduction journal, 12, 25. https://doi.org/10.1186/s12954-015-0058-x
Harm Reduction International. (2022). What is harm reduction? https://www.hri.global/what-is-harm-reduction
Holland, T. J., Penm, J., Dinh, M., Aran, S., & Chaar, B. (2019). Emergency department physicians’ and pharmacists’ perspectives on take-home naloxone: ED perspective on take-home naloxone. Drug and Alcohol Review, 38(2), 169–176. https://doi.org/10.1111/dar.12894
Lacroix, L., Thurgur, L., Orkin, A. M., Perry, J. J., & Stiell, I. G. (2018). Emergency physicians' attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian emergency departments. CJEM, 20(1), 46–52. https://doi.org/10.1017/cem.2017.390
Larner, W. (2000). Neo-liberalism: Policy, Ideology, Governmentality. Studies in Political Economy, 63(1), 5–25. https://doi.org/10.1080/19187033.2000.11675231
Leece, P. N., Hopkins, S., Marshall, C., Orkin, A., Gassanov, M. A., & Shahin, R. M. (2013). Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Canadian journal of public health = Revue canadienne de sante publique, 104(3), e200–e204. https://doi.org/10.17269/cjph.104.3788
McDonald, R., Breidahl, S., Abel-Ollo, K., Akhtar, S., Clausen, T., Day, E., Kelleher, M., McAuley, A., Petersen, H., Sefranek, M., Thiesen, H., & Strang, J. (2022). Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses. European addiction research, 28(3), 220–225. https://doi.org/10.1159/000521197
McDonald, R., & Strang, J. (2016). Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction (Abingdon, England), 111(7), 1177–1187. https://doi.org/10.1111/add.13326
Moore, D., & Fraser, S. (2006). Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications. Social science & medicine (1982), 62(12), 3035–3047. https://doi.org/10.1016/j.socscimed.2005.11.067
Neale, J., Brown, C., Campbell, A. N. C., Jones, J. D., Metz, V. E., Strang, J., & Comer, S. D. (2019). How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies. Addiction (Abingdon, England), 114(4), 708–718. https://doi.org/10.1111/add.14510
Nielsen, S., & Van Hout, M. C. (2016). What is known about community pharmacy supply of naloxone? A scoping review. The International Journal of Drug Policy, 32, 24–33. https://doi.org/10.1016/j.drugpo.2016.02.006
Sills, K. (2017). Constructing the 'Addict': A Discourse Analysis of National Newspapers Concerning North America's First Supervised Injection Site". Social Justice and Community Engagement. 26. http://scholars.wlu.ca/brantford_sjce/26
Souleymanov, R., & Allman, D. (2016). Articulating connections between the harm-reduction paradigm and the marginalisation of people who use illicit drugs. The British Journal of Social Work, 46(5), 1429–1445. https://doi.org/10.1093/bjsw/bcv067
Strang J. (2022). Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact. European addiction research, 28(3), 161–175. https://doi.org/10.1159/000519939
Viens, A. M. (2019). Neo-Liberalism, Austerity and the Political Determinants of Health. Health Care Analysis, 27(3), 147–152. https://doi.org/10.1007/s10728-019-00377-7
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., … Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ (Online), 346(jan30 5), 89–f174. https://doi.org/10.1136/bmj.f174
World Health Organization. (2014). Community management of opioid overdose. https://apps.who.int/iris/handle/10665/137462
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sibel Kusdemir, Abe Oudshoorn
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Witness publishes under a Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0). Read the license terms at https://creativecommons.org/licenses/by-nc/4.0/. The author(s) retain copyright to their works.
